What is it about?
Idiopathic pulmonary fibrosis (IPF) and lung cancer represent progressive lung diseases with a poor prognosis. Furthermore, IPF represents a risk factor for the development of lung cancer, the incidence of lung cancer is increased in patients with IPF, and both diseases share common pathomechanistical features. Using this approach, we sought to explore a common pattern of misregulated genes to eventually detect novel therapeutic targets for IPF patients.
Featured Image
Read the Original
This page is a summary of: The Oncogene ECT2 Contributes to a Hyperplastic, Proliferative Lung Epithelial Cell Phenotype in Idiopathic Pulmonary Fibrosis, American Journal of Respiratory Cell and Molecular Biology, December 2019, American Thoracic Society,
DOI: 10.1165/rcmb.2019-0047oc.
You can read the full text:
Contributors
The following have contributed to this page